EyePoint Pharmaceuticals
EYPT
#5227
Rank
C$2.04 B
Marketcap
C$24.68
Share price
0.45%
Change (1 day)
97.11%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$71.34 Million

According to EyePoint Pharmaceuticals 's latest financial reports the company's total liabilities are C$71.34 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

EyePoint Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.11 B-0.21%
2023-12-31C$0.11 B3.42%
2022-12-31C$0.11 B13.21%
2021-12-31C$0.10 B7.89%
2020-12-31C$93.3 M10.52%
2019-12-31C$84.42 M
2018-06-30C$78.87 M1036.81%
2017-06-30C$6.93 M-50.14%
2016-06-30C$13.91 M23.92%
2015-06-30C$11.22 M35.82%
2014-06-30C$8.26 M-8.02%
2013-06-30C$8.98 M26.81%
2012-06-30C$7.08 M-24.03%
2011-06-30C$9.32 M-11.64%
2010-06-30C$10.55 M-32.25%
2009-06-30C$15.58 M-40.49%
2008-06-30C$26.18 M30.32%
2007-06-30C$20.09 M-59.68%
2006-06-30C$49.83 M334.38%
2005-06-30C$11.47 M539.75%
2004-06-30C$1.79 M126.28%
2003-06-30C$0.79 M
2001-06-30C$0.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
C$0.16 B 135.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
C$4.35 M-93.89% Bahamas